On : 1 April 2025
• The global Amoxicillin Sodium API market was valued at US$ 1.8 billion in 2024 and is projected to reach US$ 2.5 billion by 2032, exhibiting a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period (2024-2032). The consistent demand for antibiotics due to rising bacterial infections, growing pharmaceutical production, and increasing global healthcare expenditure contribute to the market's expansion.
Email: help@intelmarketresearch.com +91 9169164321
• Amoxicillin Sodium API is a widely used active pharmaceutical ingredient (API) in the production of antibiotics. It is primarily used for treating bacterial infections caused by gram-positive and gram-negative bacteria. This API is available in different purity levels, with the majority of the market demand being for purity levels of 99% or higher. The pharmaceutical industry relies heavily on Amoxicillin Sodium API for producing injectable and sterile powder formulations for treatment in humans and animals.
Email: help@intelmarketresearch.com +91 9169164321
•Purity ≥ 99%
•Purity < 99%
By Applications
Injection
Sterile Powder for Injection
Sandoz
Acs Dobfar S.P.A.
Aurobindo Pharma
Fresenius Kabi Ipsum S.R.L.
Zhuhai United Laboratories
Zhejiang Prodbon Pharmaceuticals
Sichuan Ren'an Pharmaceutical
